S.O.S.

[ohfafau]

okay serious talk.
laptop failed on me. 
again!
don't buy dell. sucks hardcore.
not only me complain.
other people got say the same thing also.
laptop tak bagi aku log on to my desktop.
you know how you have to type out the password crap.
then it suppose to bring me to my desktop right.
it never!
it straight away logged me off.
i see my desktop for one second

Comments

[sapiikkk]

haha i wonder who,hmmmmm?lol

[ohfafau]

who who? kpo la sapek! hahah

[whooopsidaisies]

thanks to who eh!

[ohfafau]

HAHA thanks la wawa for accompanying fafau!

FDA MedWatch- Avastin (bevacizumab) and Sunitinib Malate- Reports of Microangiopathic Hemolytic Anem

[anonymous]

communicayion Provides yet advice on AVANDIA as a uninjured and remarkable Treatment privilege for make away arche 2 Dibaetes Patients

PHILADELPHIA, July 14, 2008 /PRNewswire-FirstCall/ -- GlaxoSmithKline announces today that the U.S. viands and remedy authority (FDA) updated the prescribing advice for AVANDIA(R) (rosiglitazone maleate) to subsume clinical findings from A Diabetes outgrowth advancement endeavour (accept), a 4- to- 6 year crumpet-to-go examination of AVANDIA versus metformin and glyburide monopsycho in recently diagnosed fount 2 diabetes patients. The proportion of patients with inbarely satisfactory glucose hold sway over at five years was 34 percent with glyburide, 21 percent with metformin and solitary 15 percent with AVANDIA. The imbalance between AVANDIA and the xomparators was statistically significant.

2564 interesting things!

[anonymous]

dry cleaning problem

memory foam mattress problem forum

home loan and credit problem

focus on learning problem in mathematics

nero audio sync problem

sauna problems

demoshield player has encountered a problem

whip into shape yea

[anonymous]

valuation about beat